Imaging experts are concerned artificial intelligence is not being trained on robust datasets, while developers say their platforms are already working in real-world situations.
Experts maintained that CXR isn't as sensitive as lab testing or even computed tomography, but suggested the modality is useful in many clinical situations.
“This is one of the first times that artificial intelligence has been used to better define the different parts of a newborn's brain on an MRI," Canadian researchers explained March 26 in Frontiers in Neuroscience.
An increasing number of artificial intelligence firms are tweaking existing platforms or creating new models to help clinicians handle the growing pandemic.
"This study presents a significant advancement in addressing a major unmet clinical need: the accurate arrhythmia localization in patients with a variety of heart rhythm disorders," one Johns Hopkins Medicine expert noted.
Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.
The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.
